糖类抗原CA19-9在卵巢畸胎瘤诊断中的临床意义  

Clinical Significance of CA19-9 in Diagnosis of Ovarian Teratoma

作　　者：张莉[1] 安永亮 李宗良[1] 

机构地区：[1]河北省邢台市人民医院核医学科,河北邢台054001 [2]河北省邢台县医院,河北邢台054001

出　　处：《标记免疫分析与临床》2015年第1期20-22,共3页Labeled Immunoassays and Clinical Medicine

摘　　要：目的研究探讨糖类抗原CA19-9在卵巢畸胎瘤诊断中的临床意义。方法选择2007年3月至2012年3月我院妇科收治的138例卵巢畸胎瘤患者,进行肿瘤标记物CA19-9检测和结果回顾分析。结果卵巢畸胎瘤患者的肿瘤标记物CA19-9阳性表达率高,并且和其年龄、瘤体大小及发于卵巢的单双侧有关。结论 CA19-9对卵巢畸胎瘤的诊断和鉴别具有一定的临床意义,结合影像学资料可指导临床对卵巢畸胎瘤进行诊治。Objective To explore the clinical significance of carbohydrate antigen 19-9 （CA19-9） in diagnisis of ovarian teratoma. Methods The retrospective analysis of the tumor marker CA19-9 test results of 138 patients in ovarian teratoma who were treated by the gynecology in our hospital was carried out. Results The positive rate of tumor marker CA19-9 in ovarian teratoma was high. The positive rate was related with the age of the patient, the size and the region （unilateral or bilateral） of the tumor. Conclusion The detection of CA19-9 has certain clinical significance in diagnosis and differential diagnosis of ovarian teratoma. The detection of CA19-9 and combined with image data could be helpful to guide the clinical diagnosis and the treatment of ovarian teratoma.

关 键 词：卵巢肿瘤 畸胎瘤 肿瘤标志物 CA19-9 

分 类 号：R737.31[医药卫生—肿瘤]